Healthcare

Pasithea Therapeutics (KTTA) stock soars 229% - Know why?

November 24, 2021 07:29 AM AEDT | By Rupam Roy

Highlights Pasithea Therapeutics' (KTTA) wholly-owned subsidiary Pasithea Clinics got approval for its anti-depressant esketamine nasal spray, SPRA...

Qualigen (QLGN) stock jumped 32% Tuesday – Is it worth the price?

November 24, 2021 06:27 AM AEDT | By Versha Jain

Highlights Qualigen Therapeutics, Inc. (NASDAQ: QLGN) soared 32% in intraday trading on Tuesday. Its third-quarter revenue rose to US$US$1.16 mill...

Aadi Bioscience (AADI) stock soars on FDA approval for FYARRO

November 24, 2021 03:07 AM AEDT | By Rupam Roy

Highlights Aadi Bioscience announced FDA approval for its injectable drug FYARRO. FYARRO is the only FDA-approved therapy for advanced malignant P...

Why is iSpecimen Inc. (ISPC) stock making headlines today?

November 23, 2021 05:26 AM AEDT | By Rupam Roy

Highlights iSpecimen Inc. (ISPC) said that it secured a contract to support new research on covid. The stocks were up more than 130% on Monday mor...

Why ObsEva SA (OBSV) stock jumped on Monday?

November 23, 2021 04:08 AM AEDT | By Rupam Roy

Highlights FDA has agreed to review the new drug application (NDA) for Linzagolix. It has set Sep 13, 2022, as a target date for the NDA review un...

Longeveron (LGVN) shares soared 138%, do you know why?

November 19, 2021 05:00 AM AEDT | By Rupam Roy

Highlights FDA has granted rare-pediatric-disease (RPD) designation to Longeveron’s cellular therapy Lomecel-B. Longeveron is currently eval...

Pfizer funding in Cardiff Oncology drives CRDF 21% higher. Know more

November 19, 2021 04:55 AM AEDT | By Versha Jain

Highlights Cardiff Oncology, Inc. (NASDAQ: CRDF) stock jumped 21% in premarket Thursday. The company has received a US$15 million equity investmen...

Dicerna-Novo Nordisk deal revealed: DRNA stock pops 78% in premarket

November 19, 2021 03:18 AM AEDT | By Versha Jain

Highlights Novo Nordisk will acquire Dicerna Pharmaceuticals for US$3.3 billion. After the acquisition, Novo expects to begin the clinical dev...

Progenity (PROG) stock continues rally, up 21%: Here’s why

November 18, 2021 03:32 AM AEDT | By Raza Naqvi

Highlights Progenity, Inc. (NASDAQ: PROG) will participate in Piper Sandler 33rd Annual Virtual Healthcare Conference The company's revenue surged...

Why did Altamira Therapeutics (CYTO) stock skyrocket today?

November 13, 2021 07:29 AM AEDT | By Ipsita Sarkar

Highlights Altamira Therapeutics Ltd. (NASDAQ: CYTO) announces positive test results for Bentrio nasal spray. The company received FDA approval fo...

Eyeing for JNJ stock? Know why J&J is splitting into 2 companies

November 13, 2021 04:53 AM AEDT | By Ipsita Sarkar

Healthcare company Johnson & Johnson (NYSE: JNJ) announced on Friday to split the business into two companies in the next two years, triggering a...

AstraZeneca (AZN) revenue skyrockets; is the stock worth exploring?

November 13, 2021 04:10 AM AEDT | By Versha Jain

Highlights AstraZeneca PLC (NASDAQ: AZN) revenue increased 50% YoY to US$9.877 billion in the third quarter ended September 30, 2021. However...

Is RenovoRx (RNXT) stock worth exploring? Know more.

November 11, 2021 05:49 AM AEDT | By Ipsita Sarkar

Highlights RenovoRx, Inc. (NASDAQ: RNXT) stock jumped over 66% in premarket on Wednesday. The company had made a presentation on its therapeutic p...

CVS (CVS), Humana (HUM) revise guidance after strong Q3 results

November 04, 2021 04:24 AM AEDT | By Versha Jain

Highlights CVS Health Corporation (NYSE: CVS) revenue rose 10% YoY to US$73.8 in Q3. Humana Inc. (NYSE: HUM) revenue rose 3% to US$20.7 billion i...

Pfizer (PFE) raises guidance after Q3 revenue jumps 134%

November 03, 2021 04:26 AM AEDT | By Versha Jain

Highlights Pfizer, Inc. (NYSE: PFE) revenue increased by 134% YoY to US$24.1 billion in Q3. The company raised guidance for fiscal 2021 after robu...

Why did ABVC stock jump more than 200% today?

November 02, 2021 03:50 AM AEDT | By Versha Jain

ABVC Biopharma, Inc. (NASDAQ: ABVC) jumped more than 219% on Monday after receiving approval from Taiwan Central Institutional Review Board to st...

AbbVie (ABBV) raises full-year guidance after Q3 revenue boost

October 30, 2021 04:09 AM AEDT | By Ipsita Sarkar

Highlights AbbVie Inc. (NYSE: ABBV) posted third-quarter revenue of US$14.342 billion, up 11.2% YoY. It raised the GAAP diluted EPS guidance to a...

Merck (MRK), Sanofi (SNY) raise profit guidance after solid Q3 resul...

October 29, 2021 03:17 AM AEDT | By Ipsita Sarkar

Highlights Merck & Company, Inc’s (MRK) sales rose 20% YoY in Q3, FY21. Merck expects its adjusted annual profit to be between US$5.65 p...

Bristol Myers (BMY), GlaxoSmithKline (GSK) post strong revenue growt...

October 28, 2021 05:18 AM AEDT | By Ipsita Sarkar

Highlights Bristol-Myers Squibb Company (NYSE: BMY) revenue surged 10% YoY to US$11.5 billion in Q3, FY21. BMY raised its low-end adjusted EPS gui...

Thermo Fisher (TMO), Boston Scientific (BSX) lift guidance after Q3...

October 28, 2021 03:23 AM AEDT | By Ipsita Sarkar

Highlights Thermo Fisher Scientific Inc’s (NYSE: TMO) revenue increased by 9% YoY in Q3, FY21. TMO raised its revenue guidance for fiscal 20...